Development and progression of nephropathy in type 2 diabetes: the United Kingdom Prospective Diabetes Study (UKPDS 64).
about
A genome-wide association for kidney function and endocrine-related traits in the NHLBI's Framingham Heart StudyESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD - SummaryVitamin B and its derivatives for diabetic kidney diseaseChinese medicinal herbs for treating diabetic kidney diseaseGlucose targets for preventing diabetic kidney disease and its progressionAntihypertensive agents for preventing diabetic kidney diseaseVitamin B and/or its derivatives for diabetic kidney diseaseChinese medicinal herbs for treating diabetic kidney diseaseAvosentan reduces albumin excretion in diabetics with macroalbuminuriaAddition of angiotensin receptor blockade or mineralocorticoid antagonism to maximal angiotensin-converting enzyme inhibition in diabetic nephropathyOxidative Stress in Diabetic Nephropathy with Early Chronic Kidney DiseaseMicrovasular and macrovascular complications in diabetes mellitus: Distinct or continuum?Clinical Predictive Factors in Diabetic Kidney Disease ProgressionPancreatic regulation of glucose homeostasisFRMD3 gene: its role in diabetic kidney disease. A narrative reviewThe role of progranulin in diabetes and kidney diseaseNon-Proteinuric Diabetic NephropathyType 2 translational research for CKDGlycated albumin is the preferred marker for assessing glycaemic control in advanced chronic kidney diseaseType 2 diabetes in East Asians: similarities and differences with populations in Europe and the United StatesBeat it early: putative renoprotective haemodynamic effects of oral hypoglycaemic agentsDiabetic kidney disease: a report from an ADA Consensus ConferenceRenal endothelial dysfunction in diabetic nephropathyDiabetic kidney disease: from physiology to therapeuticsImprovements in the Management of Diabetic NephropathyDiabetes mellitus and burns. Part I-basic science and implications for managementToday's guidanceMesenchymal Stem Cells as Therapeutic Candidates for Halting the Progression of Diabetic NephropathyDiabetic nephropathy - Epidemiology in Asia and the current state of treatmentIncidence of chronic kidney disease among people with diabetes: a systematic review of observational studies.Therapeutic management of diabetic kidney disease.Clinical therapeutic strategies for early stage of diabetic kidney disease.Is albuminuria screening and treatment optimal in patients with type 2 diabetes in primary care? Observational data of the GIANTT cohort.Prevalence, incidence and concomitant co-morbidities of type 2 diabetes mellitus in South Western Germany--a retrospective cohort and case control study in claims data of a large statutory health insuranceAlbuminuria, cardiovascular risk factors and disease management in subjects with type 2 diabetes: a cross sectional study.Correlation between albuminuria and spontaneous platelet microaggregate formation in type 2 diabetic patientsHigh prevalence and diversity of kidney dysfunction in patients with type 2 diabetes mellitus and coronary artery disease: the BARI 2D baseline dataWhat can we learn from the recent blood glucose lowering megatrials?Distribution of cardiovascular disease and retinopathy in patients with type 2 diabetes according to different classification systems for chronic kidney disease: a cross-sectional analysis of the renal insufficiency and cardiovascular events (RIACE)Longitudinal relationships among coronary artery calcification, serum phosphorus, and kidney function.
P2860
Q21261435-3AE5A8E8-D520-4759-B90C-65F1BB5E02E3Q22241786-1189D3AB-E06B-4A7A-88D7-7426312C630BQ24186641-0DC84F05-E406-434C-8922-D509A77D8844Q24192995-EA0D8B39-8AB5-4A86-B475-1EF9AD68CEC7Q24198925-97CAD184-DB2F-461C-A6DF-76B378F6DC31Q24202090-ED594177-4179-4FA4-B049-62FF7CF5073CQ24236375-234F806E-B35A-41C6-8BAE-D827E87F4B0DQ24243310-B54919F8-E7C1-4F65-8F0A-485948A95BE1Q24642372-E48A871D-7D54-46EA-9BAE-7CEB4442C539Q24657470-50B00F88-604E-411B-806C-514E980AD92DQ26741451-8D1E6B8E-DF67-4FF9-8E19-553F839CA5EBQ26745606-1F98D9FD-84C2-4A8B-8762-7796E88A0C43Q26749494-E9A20153-19B0-469B-8960-66714C8A0133Q26766485-051B35AD-9B0D-4D1A-81BC-268D417F4C5BQ26771495-84168DF0-47D2-4E31-9EB9-00BADAAC0882Q26772301-BB938585-41C9-449D-9DF6-952A2D640B6CQ26786923-8520BBE3-B447-4EA7-B66A-02C41A843581Q26823511-CF191F5D-246F-40A3-A6C5-D45B7A332E88Q26827458-AB0BC956-61CE-4463-AEAF-DC55B5564B99Q26859746-8D0D9BB1-D4D2-4F94-B00F-5808843541FBQ27010669-6DC6B3CD-C4F6-4866-94DE-E83A5EF58216Q27012546-F60022DD-0B9A-4FCD-87E6-75F3C2ABEFE7Q27021318-5382012B-AF2D-4A85-B827-5BCF6BF7ACF0Q27021392-94DCE32B-5DFC-4A62-81D2-8DDA73690C74Q28080717-6A61138D-7872-47A9-942E-6A0D8FC9C0A7Q28084664-03959AF2-6EE2-4CAB-9F7A-52924D731AD3Q28211142-FFB0371C-E670-4E8C-90B2-476653B92D98Q28354224-F84CBA54-7EAA-404E-BCFF-E71AEA71CF38Q28742785-3CCAE89F-E642-47D0-8F26-4482D78C37A3Q30238531-C8B6EAAE-FDDB-4A47-B7FE-8E80C516924FQ30362729-C98E77E2-EB2E-478B-BD88-956FC041FDA5Q30363683-820AC959-1F6A-4737-8E6F-5E3BCEE9E168Q30582848-5585CCE9-72CB-4C0A-824D-3209913916E7Q30991231-67F35E4C-AE28-44AB-B8E4-F92125635788Q33382876-8A8481E1-35C7-43DE-9CD5-3905AD7D9FCFQ33493041-78D98858-CB31-4350-B63A-E0E87624DA44Q33550730-830571AF-5E05-4E9F-974D-428C980E6CD8Q33558383-FA1D65CE-343E-47F3-8D1F-2817BD9711AEQ33558940-1CB88045-6B35-4E38-8ED7-86B948787B23Q33560460-8C6AB4A8-F523-415E-9276-3F80B061BC63
P2860
Development and progression of nephropathy in type 2 diabetes: the United Kingdom Prospective Diabetes Study (UKPDS 64).
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh-hant
name
Development and progression of ...... ive Diabetes Study (UKPDS 64).
@en
Development and progression of ...... dom Prospective Diabetes Study
@nl
type
label
Development and progression of ...... ive Diabetes Study (UKPDS 64).
@en
Development and progression of ...... dom Prospective Diabetes Study
@nl
prefLabel
Development and progression of ...... ive Diabetes Study (UKPDS 64).
@en
Development and progression of ...... dom Prospective Diabetes Study
@nl
P2093
P1433
P1476
Development and progression of ...... tive Diabetes Study (UKPDS 64)
@en
P2093
Amanda I Adler
Carole A Cull
Richard J Stevens
Rudy W Bilous
Sue E Manley
UKPDS GROUP
P304
P356
10.1046/J.1523-1755.2003.00712.X
P407
P50
P577
2003-01-01T00:00:00Z
P5875
P6179
1030027564